HYDERABAD: Eli Lilly and Company will be investing over $1 billion over the next few years in setting up new contract manufacturing facilities in India and will also set up a new manufacturing and quality hub in Hyderabad. The investment will also go into strengthening Lilly’s supply capabilities over the next few years.
The new manufacturing and quality hub in Hyderabad will offer advanced technical capabilities and oversight for its contract manufacturing network across India, Lilly said on Monday.
The US pharma giant said it will immediately begin recruitments for the new facilities with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals, and management positions.
The move is part of Lilly’s efforts to leverage India’s highly skilled talent pool to support its global manufacturing growth, it said.
Pointing out that since 2020 the company has committed over $55 billion to build, expand, and acquire facilities in the US and around the world, Lilly said: “These facilities and investments address growth from potential new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions and prepare for medicines of the future."
Patrik Jonsson , executive vice president and president Lilly International, Eli Lilly and Company, said the company is making significant investments to increase manufacturing and medicine supply capacity around the world. “Working with trusted contract manufacturers expands our capabilities to deliver life-changing medicines at greater scale — with quality always at the core. This investment reaffirms our confidence in India as a hub for capability building within our global network,” Jonsson said.
Terming Lilly’s continued expansion in Hyderabad as a validation of the city’s emergence as a global healthcare innovation powerhouse, Telangana chief minister A Revanth Reddy said: “From the recent opening of its innovation and technology site to a new manufacturing collaboration and the establishment of a manufacturing & quality hub, Lilly is moving swiftly to expand its presence in Telangana — reinforcing the state’s position as a preferred destination for cutting-edge healthcare investments.”
Telangana’s IT & industries minister D Sridhar Babu said Lilly’s expansion in Hyderabad was a testament to the state’s dynamic industrial landscape and growing influence in advanced healthcare manufacturing.
“The state’s focus on technology-driven infrastructure and ease of doing business continues to attract global leaders across sectors and life sciences sector in particular has been on accelerated growth,” Sridhar Babu said.
Lilly already has a commercial site in Gurugram as well as specialised sites in Bengaluru and Hyderabad that support global innovation and is now reinforcing its presence through strategic investments in local talent and technical capabilities.
The new manufacturing and quality hub in Hyderabad will offer advanced technical capabilities and oversight for its contract manufacturing network across India, Lilly said on Monday.
The US pharma giant said it will immediately begin recruitments for the new facilities with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals, and management positions.
The move is part of Lilly’s efforts to leverage India’s highly skilled talent pool to support its global manufacturing growth, it said.
Pointing out that since 2020 the company has committed over $55 billion to build, expand, and acquire facilities in the US and around the world, Lilly said: “These facilities and investments address growth from potential new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions and prepare for medicines of the future."
Patrik Jonsson , executive vice president and president Lilly International, Eli Lilly and Company, said the company is making significant investments to increase manufacturing and medicine supply capacity around the world. “Working with trusted contract manufacturers expands our capabilities to deliver life-changing medicines at greater scale — with quality always at the core. This investment reaffirms our confidence in India as a hub for capability building within our global network,” Jonsson said.
Terming Lilly’s continued expansion in Hyderabad as a validation of the city’s emergence as a global healthcare innovation powerhouse, Telangana chief minister A Revanth Reddy said: “From the recent opening of its innovation and technology site to a new manufacturing collaboration and the establishment of a manufacturing & quality hub, Lilly is moving swiftly to expand its presence in Telangana — reinforcing the state’s position as a preferred destination for cutting-edge healthcare investments.”
Telangana’s IT & industries minister D Sridhar Babu said Lilly’s expansion in Hyderabad was a testament to the state’s dynamic industrial landscape and growing influence in advanced healthcare manufacturing.
“The state’s focus on technology-driven infrastructure and ease of doing business continues to attract global leaders across sectors and life sciences sector in particular has been on accelerated growth,” Sridhar Babu said.
Lilly already has a commercial site in Gurugram as well as specialised sites in Bengaluru and Hyderabad that support global innovation and is now reinforcing its presence through strategic investments in local talent and technical capabilities.
You may also like
La Ore: Pakistan claims to have exported rare earth elements to US
Arunachal targets 35,723 hectares under oil palm cultivation by 2025-26: Governor
Bihar poll: NDA leaders confident of landslide victory (Lead)
1 killed, 350 rescued in Tibetan Everest blizzard; 200 still stranded
Israel, Hamas Begin Indirect Talks In Egypt On US Peace Plan For Gaza
